News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

MedImmune, Inc. (MEDI) And Pediatric Infectious Diseases Society Present First Annual "MedImmune Career Development Award" To Stanford University Physician

10/19/2005 5:09:54 PM

WASHINGTON, May 18 /PRNewswire-FirstCall/ -- The Pediatric Infectious Diseases Society (PIDS), on behalf of MedImmune, Inc. , presented the MedImmune Career Development Award in Pediatric Infectious Disease to Manuel Amieva, M.D., Ph.D., of Stanford University School of Medicine. The award, which includes a $50,000 per year grant for up to three years, was established to support the development of outstanding physician- scientists as independent investigators in the field of pediatric infectious diseases, aiming to foster their research productivity in their initial years as faculty. PIDS presented the award to Dr. Amieva on May 16 at a dinner coinciding with the annual meeting of the Pediatric Academic Societies in Washington, DC.

"The career development award is an extension of MedImmune's commitment to the pediatric research community," said Alan H. Cohen, M.D., FAAP, FCCP, Senior Director of Medical Affairs at MedImmune, Inc. "Each year, thousands of children and adults suffer from illnesses caused by viral and bacterial respiratory pathogens. Dr. Amieva's research over the next three years may lead to new and important discoveries in pediatric infectious illnesses, benefiting all children."

The Research Affairs Committee of PIDS selected Dr. Amieva based on his scientific accomplishments and the quality of his research proposal. Eligible applicants were required to be trained in pediatric infectious diseases, to have completed three years of fellowship training, to be engaged in laboratory research and to hold a full-time academic position.

"The review committee selected Dr. Amieva to receive the career development award based on his outstanding commitment to research in the area of pediatric infectious diseases and his promise for success," commented Joseph St. Geme, M.D, president, Pediatric Infectious Diseases Society. "Dr. Amieva is most deserving, and we are pleased that this funding will support his continued work on the relationship between Helicobacter pylori infection and carcinogenesis."

Dr. Amieva is an Assistant Professor of Pediatrics, Microbiology and Immunology at Stanford University School of Medicine, where he received his medical degree and Ph.D. in cancer biology. Dr. Amieva is from Mexico City, Mexico.

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With approximately 2,000 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at

MedImmune, Inc.

CONTACT: Clarencia Stephen of MedImmune, Inc., +1-301-398-4073

Read at

comments powered by Disqus